Related Experiment Video
Updated: Jan 12, 2026

Murine Model of Epicutaneously-Induced Immunomodulation
Published on: June 24, 2025
High-fat diet exacerbates atopic dermatitis through alterations in the gut microbiome
Keito Tabata1, Nobutomo Ikarashi1, Ryotaro Yoshida1
1Department of Biomolecular Pharmacology, Hoshi University, Tokyo, Japan.
A high-fat diet worsens atopic dermatitis (AD) by altering gut bacteria and reducing beneficial short-chain fatty acids (SCFAs). Acetate supplementation can alleviate AD symptoms, suggesting its potential for treatment.
Area of Science:
- Dermatology
- Microbiology
- Immunology
Background:
- Atopic dermatitis (AD) is a chronic skin condition influenced by genetics and environmental factors like diet.
- High-fat diets (HFDs) are suspected contributors to AD exacerbation, but the underlying mechanisms require further investigation.
Purpose of the Study:
- To investigate the impact of a high-fat diet on the pathogenesis of atopic dermatitis.
- To explore the role of gut microbiota and short-chain fatty acids (SCFAs) in HFD-induced AD exacerbation.
Main Methods:
- Atopic dermatitis was induced in mice fed either a normal or high-fat diet (HFD).
- Skin inflammation markers and AD-related factors were quantified.
- Gut microbiota composition and SCFA levels in cecal contents were analyzed.
- Fecal microbiota transplantation and acetate administration were performed.
Main Results:
- HFD significantly increased inflammatory markers and AD-related factors in the skin.
- HFD altered gut microbiota, decreasing SCFA-producing bacteria (Bacteroides acidifaciens, Parabacteroides distasonis) and reducing SCFA levels.
- Fecal microbiota transplantation confirmed the link between gut dysbiosis and AD exacerbation.
- Acetate administration ameliorated HFD-induced skin inflammation and AD-like symptoms.
Conclusions:
- High-fat diet intake exacerbates atopic dermatitis-like symptoms through gut microbiota alterations and reduced SCFA production.
- Acetate and acetate-producing bacteria show potential as therapeutic strategies for managing AD.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

